These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 3894520

  • 21. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE, Grabstein KH, Okuno K, Schreiber RD, Greenberg PD.
    J Immunol; 1989 Dec 15; 143(12):4308-16. PubMed ID: 2687379
    [Abstract] [Full Text] [Related]

  • 22. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T, Shu S.
    J Immunol; 1987 Sep 15; 139(6):2103-9. PubMed ID: 2957448
    [Abstract] [Full Text] [Related]

  • 23. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
    Sypek JP, Panosian CB, Wyler DJ.
    J Immunol; 1984 Dec 15; 133(6):3351-7. PubMed ID: 6333458
    [Abstract] [Full Text] [Related]

  • 24. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL, Lazdins JK, Hieny S, Natovitz P.
    J Immunol; 1983 Sep 15; 131(3):1481-6. PubMed ID: 6350456
    [Abstract] [Full Text] [Related]

  • 25. Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis.
    Deepe GS, Watson SR, Bullock WE.
    J Immunol; 1984 Apr 15; 132(4):2064-71. PubMed ID: 6230399
    [Abstract] [Full Text] [Related]

  • 26. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
    Guerne PA, Piguet PF, Vassalli P.
    J Immunol; 1983 May 15; 130(5):2225-30. PubMed ID: 6187845
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB, Ye QW.
    Cancer Res; 1985 Oct 15; 45(10):4932-9. PubMed ID: 4027979
    [Abstract] [Full Text] [Related]

  • 30. Enhanced induction of tumor-specific Lyt-1+2- T cell-mediated protective immunity by in vivo administration of interleukin 1.
    Izumi Y, Tsuchida T, Okuno K, Fujiwara H, Hamaoka T.
    Jpn J Cancer Res; 1985 Sep 15; 76(9):863-70. PubMed ID: 3932286
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
    Biondi A, Roach JA, Schlossman SF, Todd RF.
    J Immunol; 1984 Jul 15; 133(1):281-5. PubMed ID: 6373929
    [Abstract] [Full Text] [Related]

  • 33. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I, Komuta K, Ogura T, Fujiwara H, Hamaoka T, Kishimoto S.
    Cancer Res; 1985 Apr 15; 45(4):1663-8. PubMed ID: 3978634
    [Abstract] [Full Text] [Related]

  • 34. Preparation and antitumor effect of macrophage activating factor (MAF) encapsulated in liposomes bearing a monoclonal anti-human melanoma (A375) antibody.
    Watanabe Y, Uchida E, Higuchi M, Imai Y, Osawa T.
    J Biol Response Mod; 1987 Oct 15; 6(5):556-68. PubMed ID: 3316511
    [Abstract] [Full Text] [Related]

  • 35. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T, Igarashi T, Kishimoto S.
    J Natl Cancer Inst; 1987 Mar 15; 78(3):509-17. PubMed ID: 2950265
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G, Kirsh R, Fogler WE, Fidler IJ.
    Cancer Res; 1979 Mar 15; 39(3):881-92. PubMed ID: 427777
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC, Rodrigues D.
    J Natl Cancer Inst; 1982 Oct 15; 69(4):867-72. PubMed ID: 6214653
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.